Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 48 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 3.7 to 3.
Financials
Financial year 2025
Apotheek Huys-Van Hecke from Hasselt, company number BE0885737286, closed financial year 2025 with a result of € -20,354 after tax. For that financial year Apotheek Huys-Van Hecke recorded a gross margin of € 175,959 and equity of € 34,880. Compared with financial year 2024, the result moved from € 50,629 to € -20,354. The company made a loss. The buffer shrank hard: equity is 91 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 34,880
▼ 91% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -20,354
▼ still € 50,629 profit in 2024
Profit after tax over the fiscal year.
€ 65,965
▼ 8% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 16,280.
People and assets in 2025
3
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 168,496
▼ 22% vs 2024
€ 56,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 902
▼ 85% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 50,000
Loans from banks and other lenders, long and short.
€ 261,194
▲ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 14,973
▼ 48% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 221,144 | € 234,060 | € 291,424 | € 175,959 | ▼ 40% |
| Profit after taxes | € -5,639 | € -9,312 | € 50,629 | € -20,354 | ▼ € 70,983 |
| Equity | € 368,554 | € 359,243 | € 374,194 | € 34,880 | ▼ 91% |
| Total debts | € 333,208 | € 361,101 | € 344,528 | € 360,677 | ▲ 5% |
| Cash | € 147,474 | € 100,700 | € 71,464 | € 65,965 | ▼ 8% |
| Land & buildings | € 6,377 | € 4,538 | € 2,700 | € 1,279 | ▼ 53% |
| Retained profit | € 349,954 | € 340,643 | € 355,594 | € 16,280 | ▼ 95% |
| Dividend | € 0 | € 0 | € 35,678 | € 318,960 | ▲ € 283,282 |
| Bank debt | € 50,000 | € 50,000 | € 50,000 | € 50,000 | |
| Balance sheet total | € 701,762 | € 720,344 | € 718,722 | € 395,556 | ▼ 45% |
| Employees (FTE) | 3.7 | 3.7 | 3.3 | 3 | ▼ 0.3 |
Key figures of Apotheek Huys-Van Hecke, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Huys-Van Hecke?
What happened at Apotheek Huys-Van Hecke in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 20,354 (▼ € 70,983 vs 2024). Source: NBB ↗
- MEES MANAGEMENT APOTHEEK BV became a director. NBB
- New establishment in Hasselt. KBO
- Start of the company according to the CBE. KBO
In short
From € 5,639 loss in 2022 to € 20,354 loss in 2025.
Paid € 6,491 in corporate taxes since 2022.
Best year ever: 2024, with € 50,629 profit.
On average € 58,700 of value added per employee in 2025.
A new publication or filing at Apotheek Huys-Van Hecke? We notify you, reason included.
Follow Apotheek Huys-Van HeckeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MEES MANAGEMENT APOTHEEK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek Huys-Van HeckeBehind Apotheek Huys-Van Hecke is MEES MANAGEMENT APOTHEEK BV. The shares are held by MEES MANAGEMENT APOTHEEK (100%).
Directors
According to the 2025 annual accounts
Director · represented by Joris Mees
Also active at: APOTHEEK MEES HASSELT, APOTHEEK MEES HAACHT CENTRUM, APOTHEEK VAN GORP, APOTHEEK MEES ZONHOVEN, APOTHEEK JANS, APOTHEEK MEES SCHULEN, APOTHEEK MEES HERK-DE-STAD, APOTHEEK MEES SINT-TRUIDEN +14 more
since 2017
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Demerstraat 38
3500 Hasselt
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0885.737.286
- VAT number
- BE 0885.737.286
- Registered office
- Demerstraat 38, 3500 Hasselt
- Names & denominations
- Apotheek Huys-Van Hecke
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2006
- Peppol
- Active · Active since 22 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers